The New York Times - Dr. Scott Friedman: "Hepatitis C, a Silent Killer, Meets Its Match"
Many doctors are now "warehousing" Hepatitis C patients - urging them to forgo treatment until the new drugs, such as sofosbuvir, are approved. "There's no way I'm going to put them on an interferon regimen when we're a year away from having interferon-free regimens," said Scott Friedman, MD, the Chief of Liver Diseases at the Icahn School of Medicine at Mount Sinai. "It's rare you have to pull the trigger and get them on treatment in that period of time." Learn more